Share this post on:

Product Name :
Isoconazole Nitrate

Search keywords :
Cytochrome P450 2C9

drugId :
null

Target Vo:
Cytochrome P450 2C9

Target Vo Short Name :
CYP2C9

Moa_Name:
Cytochrome P450 2C9 inhibitors

First Approval Country :
United States

First Approval Date Filter:
1982

Origin Company_Name :

Active Company_Name :
Hikma Pharmaceuticals

Active Indication_Name:
Skin Diseases, Infectious

In Active Indication_Name:
Onychomycosis

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Galcanezumab CGRP Receptor
Beta-Catenin Rabbit mAb Purity
FGFR1 Antibody: FGFR1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 100,140 kDa, targeting to FGFR1. It can be used for WB,ICC/IF assays with tag free, in the background of Human.

Share this post on:

Author: Interleukin Related